These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Treatment with intravenous indomethacin of symptomatic ductus arteriosus in premature newborn infants]. Valls i Soler A, Benito J, Pastor E, López Heredia I, Santiago M, Cabrera A. An Esp Pediatr; 1987 Aug; 27(2):112-6. PubMed ID: 3662265 [Abstract] [Full Text] [Related]
25. High efficacy and minor renal effects of indomethacin treatment during individualized fluid intake in premature infants with patent ductus arteriosus. Leonhardt A, Strehl R, Barth H, Seyberth HW. Acta Paediatr; 2004 Feb; 93(2):233-40. PubMed ID: 15046280 [Abstract] [Full Text] [Related]
26. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Noori S, McCoy M, Friedlich P, Bright B, Gottipati V, Seri I, Sekar K. Pediatrics; 2009 Jan; 123(1):e138-44. PubMed ID: 19117835 [Abstract] [Full Text] [Related]
27. Patent ductus arteriosus in African preterm infants. Musoke RN, Anabwani GA. East Afr Med J; 1991 Aug; 68(8):637-41. PubMed ID: 1765017 [Abstract] [Full Text] [Related]
29. Indomethacin-induced early patent ductus arteriosus closure cannot be predicted by a decrease in pulse pressure. Lubetzky R, Mandel D, Mimouni FB, Diamant S, Birger A, Barak M, Dollberg S. Am J Perinatol; 2004 Jul; 21(5):257-61. PubMed ID: 15232757 [Abstract] [Full Text] [Related]
32. Is surgical closure of patent ductus arteriosus a safe procedure in premature infants? Russell JL, Leblanc JG, Potts JE, Sett SS. Int Surg; 1998 Jul; 83(4):358-60. PubMed ID: 10096762 [Abstract] [Full Text] [Related]
33. Patent ductus arteriosus in very low birthweight infants: complications of pharmacological and surgical treatment. Koehne PS, Bein G, Alexi-Meskhishvili V, Weng Y, Bührer C, Obladen M. J Perinat Med; 2001 Jul; 29(4):327-34. PubMed ID: 11565202 [Abstract] [Full Text] [Related]
34. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Malviya M, Ohlsson A, Shah S. Cochrane Database Syst Rev; 2003 Jul; (3):CD003951. PubMed ID: 12917997 [Abstract] [Full Text] [Related]
35. Treatment of patent ductus arteriosus. Wyllie J. Semin Neonatol; 2003 Dec; 8(6):425-32. PubMed ID: 15001114 [Abstract] [Full Text] [Related]
36. Indomethacin therapy for patent ductus arteriosus in premature infants: efficacy of a dosing strategy based on a second-dose peak plasma indomethacin level and estimated plasma indomethacin levels. O'Donovan DJ, Fernandes CJ, Nguyen NY, Adams K, Adams JM. Am J Perinatol; 2004 May; 21(4):191-7. PubMed ID: 15168317 [Abstract] [Full Text] [Related]
37. Aortic flow velocity curves in the diagnosis and the followup of symptomatic patent ductus arteriosus in preterm infants during therapeutic interventions. Ulmer HE, Knapp G, Wolf D, Wille L, Seyberth HW. Pediatr Pharmacol (New York); 1983 May; 3(3-4):167-74. PubMed ID: 6677870 [Abstract] [Full Text] [Related]